Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
8.23
+0.43 (5.51%)
Jan 12, 2026, 4:00 PM EST - Market closed
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of $8.34 million as of January 12, 2026. Its market cap has increased by 24.03% in one year.
Market Cap
8.34M
Enterprise Value
5.64M
1-Year Change
24.03%
Ranking
Category
Stock Price
$8.23
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from $323.99M to $8.34M, a decrease of -97.42%. That is a compound annual growth rate of -17.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 8.34M | 2.15% |
| Dec 30, 2025 | 8.17M | 31.74% |
| Dec 30, 2024 | 6.20M | -15.53% |
| Dec 29, 2023 | 7.34M | -34.64% |
| Dec 30, 2022 | 11.23M | -73.95% |
| Dec 30, 2021 | 43.12M | -28.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |